Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD

NACompletedINTERVENTIONAL
Enrollment

1,450

Participants

Timeline

Start Date

December 12, 2014

Primary Completion Date

December 12, 2020

Study Completion Date

December 12, 2020

Conditions
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions
OTHER

Blood Collection

Phenotype and Genotype Analysis, Biological Analysis

Trial Locations (25)

2900

AUB Santé, Quimper

22000

Hôpital Yves Le Foll, Saint-Brieuc

29000

CH Laënnec, Quimper

29200

AUB Brest, Brest

Centre de néphrologie et de dialyse d'Armorique, Brest

29609

CHRU Brest, Brest

29680

Centre de Pérharidy, Roscoff

35033

Hôpital Pontchaillou, Rennes

35403

CH Saint Malo, St-Malo

44093

Hôpital Hôtel Dieu - CHU Nantes, Nantes

44402

Echo Csmn, Rezé

44606

CH de Saint Nazaire, Saint-Nazaire

44821

ECHO Centre Ambulatoire, Saint-Herblain

49933

CHU Angers, Angers

53000

CH Laval, Laval

56017

CH Bretagne Atlantique - Site de Vannes, Vannes

56100

Centre de dialyse de Lorient, Lorient

CH Bretagne Sud, Lorient

56306

CHCB site de Noyal Pontivy, Pontivy

72000

CH du Mans, Le Mans

72016

ECHO dialyse, Le Mans

79021

CH Niort, Niort

85109

ECHO les Sables d'Olonne, Olonne-sur-Mer

86021

Hôpital Jean Bernard - CHU Poitiers, Poitiers

MD

Hôpital Bretonneau - CHU Tours, Tours

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT02112136 - Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD | Biotech Hunter | Biotech Hunter